The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy

被引:8
作者
Prowse, S. J. B. [1 ]
Shaw, R. [2 ,3 ,4 ]
Ganeshan, D. [1 ]
Prowse, P. M. [2 ]
Hanlon, R. [1 ]
Lewis-Jones, H. [1 ]
Wieshmann, H. [1 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Dept Radiol, Liverpool L9 7AL, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Dept Head & Neck Surg, Liverpool L9 7AL, Merseyside, England
[3] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England
[4] Univ Liverpool, Liverpool Canc Res UK Ctr, Liverpool L69 3BX, Merseyside, England
关键词
Positron-Emission Tomography and Computed Tomography; Head and Neck Neoplasms; Neoplasms; Unknown Primary; Neoplasm Metastasis; Diagnostic Imaging; SQUAMOUS-CELL CARCINOMA; CERVICAL METASTASES; OCCULT PRIMARY; PRIMARY TUMORS; FDG-PET; DUAL-MODALITY; HEAD; CANCER; IMPACT;
D O I
10.1017/S002221511300162X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: The search for a primary malignancy in patients with a metastatic cervical lymph node is challenging yet ultimately of utmost clinical importance. This study evaluated the efficacy of positron emission tomography computed tomography in detecting the occult primary, within the context of a tertiary referral centre head and neck cancer multidisciplinary team tumour board meeting. Methods: Thirty-two patients (23 men and 9 women; mean and median age, 61 years) with a metastatic cervical lymph node of unknown primary origin, after clinical examination and magnetic resonance imaging, underwent positron emission tomography computed tomography. Results: The primary tumour detection rate was 50 per cent (16/32). Positron emission tomography computed tomography had a sensitivity of 94 per cent (16/17) and a specificity of 67 per cent (10/15). Combining these results with those of 10 earlier studies of similar patients gave an overall detection rate of 37 per cent. Conclusion: Positron emission tomography computed tomography has become an important imaging modality. To date, it has the highest primary tumour detection rate, for head and neck cancer patients presenting with cervical lymph node metastases from an unknown primary.
引用
收藏
页码:780 / 787
页数:8
相关论文
共 35 条
  • [21] Mendenhall WM, 1998, HEAD NECK-J SCI SPEC, V20, P739
  • [22] MUIR C, 1995, CANCER, V75, P353, DOI 10.1002/1097-0142(19950101)75:1+<353::AID-CNCR2820751317>3.0.CO
  • [23] 2-P
  • [24] Nassenstein K, 2007, ACTA RADIOL, P1
  • [25] Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
    Park J.S.
    Yim J.-J.
    Kang W.J.
    Chung J.-K.
    Yoo C.-G.
    Kim Y.W.
    Han S.K.
    Shim Y.-S.
    Lee S.-M.
    [J]. BMC Research Notes, 4 (1)
  • [26] Cancer of unknown primary (CUP)
    Pavlidis, N
    Fizazi, K
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 54 (03) : 243 - 250
  • [27] Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities
    Regelink, G
    Brouwer, J
    de Bree, R
    Pruim, J
    van der Laan, BFAM
    Vaalburg, W
    Hoekstra, OS
    Comans, EFI
    Vissink, A
    Leemans, CR
    Roodenburg, JLN
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (08) : 1024 - 1030
  • [28] Utility of combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors
    Roh, Jong-Lye
    Kim, Jae Seung
    Lee, Jeong Hyun
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    [J]. ORAL ONCOLOGY, 2009, 45 (03) : 218 - 224
  • [29] The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor
    Rusthoven, KE
    Koshy, M
    Paulino, AC
    [J]. CANCER, 2004, 101 (11) : 2641 - 2649
  • [30] Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination
    Schache, Andrew G.
    Liloglou, Triantafilos
    Risk, Janet M.
    Filia, Anastasia
    Jones, Terence M.
    Sheard, Jon
    Woolgar, Julia A.
    Helliwell, Timothy R.
    Triantafyllou, Asterios
    Robinson, Max
    Sloan, Philip
    Harvey-Woodworth, Colin
    Sisson, Daniel
    Shaw, Richard J.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (19) : 6262 - 6271